CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $243,000 | +3.0% | 55,150 | -11.5% | 0.00% | 0.0% |
| Q1 2016 | $236,000 | -4.8% | 62,350 | +165.2% | 0.00% | +33.3% |
| Q3 2015 | $248,000 | -38.8% | 23,510 | +61.9% | 0.00% | -25.0% |
| Q1 2015 | $405,000 | -71.8% | 14,520 | -81.6% | 0.00% | -55.6% |
| Q4 2014 | $1,438,000 | +165.3% | 78,800 | +88.5% | 0.01% | +350.0% |
| Q3 2014 | $542,000 | +66.3% | 41,800 | +109.3% | 0.00% | +100.0% |
| Q2 2014 | $326,000 | -65.5% | 19,971 | -48.8% | 0.00% | -80.0% |
| Q4 2013 | $945,000 | +193.5% | 39,000 | +328.6% | 0.01% | +150.0% |
| Q3 2013 | $322,000 | +96.3% | 9,100 | -13.2% | 0.00% | +100.0% |
| Q2 2013 | $164,000 | – | 10,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |